Leveraging MYC as a Therapeutic Treatment Option for TNBC

Oncoscience - United States
doi 10.18632/oncoscience.424
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Impact Journals, LLC

Related search

Urinary Trypsin Inhibitor as a Therapeutic Option for Inflammatory Disorders

OA Biotechnology
2013English

Guided Imagery as a Treatment Option for Fatigue

Journal of Holistic Nursing
Nursing
2011English

Darunavir: Review of Its Efficacy as a Therapeutic Option for Treatment-Naïve and Treatment-Experienced Adults and Adolescents

Clinical Medicine Reviews in Therapeutics
2010English

Dantrolene as a Treatment Option for RYR1-related Rhabdomyolysis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2016English

Pulmonary Arteriovenous Malformations: Lung Transplantation as a Therapeutic Option

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
1999English

A New Horizon: Oxytocin as a Novel Therapeutic Option for Obesity and Diabetes

Drug Discovery Today: Disease Mechanisms
2013English

Tailored Thoracomyoplasty as a Valid Treatment Option for Chronic Postlobectomy Empyema

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2012English

G115(P) Acceptability of Hypnotherapy as a Treatment Option for Habit Cough

2018English

Spinal Cord Stimulation as a Treatment Option for Intractable Neuropathic Cancer Pain

Clinical Medicine and Research
MedicineHome CareCommunity
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy